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ABSTRACT 
Breast cancer is the most common malignancy worldwide, especially among women, with 
substantial after-treatment effects. The survival rates of breast cancer have decreased over the 
years even with the existence of various therapeutic strategies, specifically, chemotherapy. 
Clinical drugs administered for breast cancer appear to be non-targeting to specific cancer 
sites leading to severe side effects and potentially harming healthy cells instead of just killing 
cancer cells. This leads to the need for designing a targeted drug delivery system. 
Nanomaterials, both organic and inorganic, are potential drug nanocarriers with the ability of 
targeting, imaging and tracking. Various types of nanomaterials have been actively 
researched together with their drug conjugate. In this review, we focus on selected 
nanomaterials, namely solid-lipid, liposomal, polymeric, magnetic nanoparticles, quantum 
dots, and carbon nanotubes and their drug conjugates, for breast cancer studies. Their 
advantages, disadvantages and previously conducted studies were highlighted. 
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